NeuroSense Therapeutics Ltd. (NRSN:NASDAQ) shot up at $3.38, a gain of 23.4%. On Thu, Jun 30, 2022, NRSN:NASDAQ touched a New 2-Week High of $3.38. The stock got featured on our News Catalysts scanner on Thu, Jun 30, 2022 at 12:13 PM in the 'BIOTECH' category. From Fri, Jun 17, 2022, the stock recorded 87.50% Up Days and 55.56% Green Days
The stock spiked on Thu, Jun 30, 2022 at $4.47 with a volume of 77M+.
About NeuroSense Therapeutics Ltd. (NRSN:NASDAQ)
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these...
Top 10 Gainers:
- Ensysce Biosciences Inc. (ENSC:NASDAQ), 73.09%
- Agrico Acquisition Corp. (RICO:NASDAQ), 43.66%
- Fast Radius Inc. (FSRD:NASDAQ), 37.23%
- Yoshitsu Co. Ltd (TKLF:NASDAQ), 36.29%
- Rapid Micro Biosystems Inc. (RPID:NASDAQ), 35.22%
- Aytu BioScience, Inc. (AYTU:NASDAQ), 33.64%
- RiceBran Technologies (RIBT:NASDAQ), 29.57%
- Volcon Inc. (VLCN:NASDAQ), 26.9%
- Tuniu Corporation (TOUR:NASDAQ), 25.99%
- NeuroSense Therapeutics Ltd. (NRSN:NASDAQ), 23.36%